Objective The aims were twofold:(a) to map tools documented in the literature to evaluate
comfort among patients undergoing high flow nasal cannula (HFNC) treatment; and (b) to …

Background An estimated 20% of emergency department (ED) patients require respiratory
support (RS). Evidence suggests that nasal high flow (NHF) reduces RS need. Aims This …

OBJECTIVE: High-flow nasal oxygen (HFNO) therapy is frequently applied outside ICU
setting in hypoxemic patients with COVID-19. However, safety concerns limit more …

Background High‐flow nasal cannula (HFNC) therapy is a non‐invasive respiratory
treatment characterized by high tolerability, which largely derives from the patient's comfort …

Background: Optimal oxygen supply is the cornerstone of the management of critically ill
patients after extubation. High flow oxygen system is an alternative to standard oxygen …

High-flow nasal cannula (HFNC) is widely used to treat hypoxemic respiratory failure. The
effectiveness of HFNC treatment and the methods for monitoring its efficacy in the general …

Introduction To assess the efficacy and safety of high-flow nasal cannula (HFNC) in elderly
patients with acute respiratory failure (ARF) not due to COVID-19, refractory to treatment with …

Objectives High-flow nasal cannula (HFNC) was widely used during the COVID-19
pandemic in intensive care units (ICU), but there is no recommendation for elderly patients …

Background High-flow nasal oxygen therapy (HFNO) is used in diverse hospital settings to
treat patients with acute respiratory failure (ARF). This systematic review aims to summarise …

Purpose Identifying thresholds at which the ROX index would satisfactorily predict HFNC
failure across heterogenous resourced contexts is necessary for clinical use. Methods …